Cordlife Medical Phils., Inc.
Cordlife Medical Phils., Inc. is a Quezon City-based, DOH-registered cord blood and cord lining stem cell bank founded in 2008 as a Philippine subsidiary of SGX-listed Cordlife Group. It serves Filipino expecting parents through 150+ hospital collection partnerships, a direct sales force, and reproductive diagnostics.
- Company typePrivate
- Founded2008
- HeadquartersQuezon City, Philippines
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Cordlife Medical Phils., Inc. does
Cordlife Medical Phils., Inc. is a Quezon City-based private cord blood and cord lining stem cell banking company founded in 2008, operating as a Philippine subsidiary of Singapore-listed Cordlife Group Limited. From its DOH-registered, ISO 9001:2015-certified, and AABB-accredited facility at UP-AyalaLand Technohub, the company collects, processes, and cryogenically stores umbilical cord blood and umbilical cord lining stem cells for Filipino expecting parents, reporting 20,000+ locally banked clients, 77 successful cord blood releases with 100% physician acceptance, and 30,000 units of installed storage capacity.
Cordlife Medical Phils., Inc. firmographics
Firmographics- Name
- Cordlife Medical Phils., Inc.
- Legal name
- Cordlife Medical Phils., Inc.
- Website
- https://cordlife.ph
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Cordlife Medical Phils., Inc. is a Quezon City-based, DOH-registered cord blood and cord lining stem cell bank founded in 2008 as a Philippine subsidiary of SGX-listed Cordlife Group. It serves Filipino expecting parents through 150+ hospital collection partnerships, a direct sales force, and reproductive diagnostics.
- Ownership category
- akta.pro rank
Cordlife Medical Phils., Inc. industry classification
Industry- Product category
- Stem Cell Banking Services
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
- akta.pro secondary industry
- Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)
Keywords
Where Cordlife Medical Phils., Inc. is headquartered
LocationHeadquarters
- HQ city
- Quezon City
- HQ country
- Philippines
- HQ region
- Asia
Offices1 record
Markets served
Cordlife Medical Phils., Inc. business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Umbilical Cord Blood Banking: Subscription-based cord blood banking service where parents pay monthly installments (starting from PHP 10,000+/month for 36 months) covering an 18-year storage period. Includes processing and cryogenic storage of stem cells.
- Umbilical Cord Lining Banking: Additional storage service for cord lining stem cells containing mesenchymal stem cells (MSCs) and cord lining epithelial stem cells (CLEpSCs) as part of comprehensive stem cell banking.
- Cordlife NIPT (Non-Invasive Prenatal Testing): Blood test service for pregnant women starting at 10 weeks gestation to screen for chromosomal abnormalities using Whole Genome Sequencing technology.
- Baby Genetic Screening: Genetic screening service analyzing risks related to chromosomal abnormalities that may lead to Childhood Developmental And Behavioral Disorders (CDABD), screening for 241 rare genetic diseases via SNP microarray.
- Value-Added Services: Cordlife Shield (pregnancy insurance), Transplant Care (transplant subsidy up to SGD 50,000), Cord Blood Network (assisted search for matching cord blood), and Cordlife Alliance (community banking program).
- Plan Upgrade Services: Upgrade options for existing clients to premium plans offering extended storage benefits and additional perks.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Standard 18-Year Cord Blood Banking Plan |
| Subscription | Monthly | Cord Blood and Cord Lining Combined Storage |
| Subscription | Multi-year contract | Prestige Value Plan Upgrade |
| Other | Pay-as-you-go | Referral Incentive Program |
| Unit Pricing | Pay-as-you-go | Cordlife NIPT Packages |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels7 records
Cordlife Medical Phils., Inc. product offering
Product offeringCore offering
Cordlife Medical Phils., Inc. collects, processes, and cryogenically stores umbilical cord blood and cord lining stem cells at its Quezon City facility for Filipino expecting parents. The company offers 18-year storage plans covering the child, parents, and grandparents. It also provides prenatal and pediatric diagnostic services including non-invasive prenatal testing (NIPT) using whole genome sequencing and baby genetic screening for 241 rare diseases.
Product overview
Cordlife Medical Philippines is a subsidiary of Cordlife Group Limited, providing umbilical cord stem cell banking and prenatal/pediatric diagnostic services. The core offering consists of Cord Blood Stem Cell Banking and Cord Lining Stem Cell Banking, where umbilical cord biological materials are collected at partnered hospitals, processed, and stored cryogenically at the company's UP-AyalaLand Technohub facility in Quezon City for potential future medical use. The company offers related diagnostic products including Cordlife NIPT (Non-Invasive Prenatal Testing using Whole Genome Sequencing for chromosomal abnormality screening) and Cordlife Baby Genetic Screening (analyzing 241 rare genetic diseases via SNP microarray). Value-added services include Cordlife Alliance (community banking for cross-matching), Cordlife Care 360° (quality assurance and emergency backup protection), Cordlife Shield (pregnancy insurance), Transplant Care (transplant cost subsidy up to SGD50,000), and Cord Blood Network (assisted donor search via China registries). The company is DOH-registered, ISO 9001:2015 certified, and AABB-accredited, serving Filipino families seeking biological insurance for future healthcare needs.
Differentiator
Problem solved
Functional benefit
Brands
- Cordlife Alliance: Community banking program allowing members to access cord blood units from various Asian countries where Cordlife operates.
- Cordlife Shield
- Transplant Care
- CordBlood Network
- Cordlife Care 360°
- Cordlife NIPT
- Cordlife Baby Genetic Screening
Products and services
- Cord Blood Stem Cell Banking Collection, processing, and cryogenic storage of umbilical cord blood stem cells at the company's Quezon City facility for potential future medical treatment of the child and family members. Coverage includes an 18-year storage period.
- Cord Lining Stem Cell Banking Storage of umbilical cord lining stem cells, including mesenchymal stem cells (MSCs) and cord lining epithelial stem cells (CLEpSCs), offering regenerative treatment potential beyond cord blood.
- Cordlife NIPT (Non-Invasive Prenatal Testing) Blood test for pregnant women starting at 10 weeks of gestation that screens for common chromosomal abnormalities using Whole Genome Sequencing technology.
- Cordlife Baby Genetic Screening (BGS) Genetic screening analyzing risks related to chromosomal abnormalities that may lead to Childhood Developmental and Behavioral Disorders (CDABD), screening for 241 rare genetic diseases via SNP microarray.
- Cordlife Alliance (Community Banking Program) Community banking program allowing members to access a diverse pool of cord blood units from various Asian countries for increased chance of finding a matching unit.
- Cordlife Shield (Pregnancy Insurance) Pregnancy insurance providing coverage for 7 types of pregnancy complications, 16 types of congenital illnesses, and maternal or child death.
- Transplant Care Transplant subsidy providing a one-time payment of up to SGD50,000 to partially cover medical costs of transplantation for the child, siblings, parents, or grandparents.
- Cord Blood Network Assisted search for matching cord blood for legal parents and grandparents of a Cordlife child, tapping partner registries in Mainland China.
Quantifiable outcome
- 100% physician acceptance rate for all cord blood releases
- +4 more outcomes
Companies that use Cordlife Medical Phils., Inc.
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles2 records
Cordlife Medical Phils., Inc. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Cordlife Medical Phils., Inc. partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- UP-AyalaLand TechnohubcoreCordlife Philippines operates its headquarters and cryogenic storage facility within the UP-AyalaLand Technohub complex in Quezon City, Metro Manila. This location provides access to academic and business infrastructure.
- MVE (Chart Industries)coreCordlife uses MVE Anti-contamination Vapour-phase Liquid Nitrogen Storage Systems for long-term stem cell cryopreservation. These tanks are designed to remain operational even without electrical supply and have never been recalled by the U.S. FDA or manufacturer.
- KK Women's & Children's HospitalminorSingapore hospital listed as a treatment facility for cord blood transplant recipients. Multiple cord blood releases have been used at this hospital for conditions including Acute Lymphoblastic Leukaemia, Neuroblastoma, and Autism Spectrum Disorder.
- Gleneagles Kuala LumpurminorMalaysian hospital listed as a treatment facility for cord blood transplant recipients. Several autism spectrum disorder treatments have been conducted at this facility.
- University Malaya Medical CentreminorMalaysian medical center listed as a treatment facility for cord blood transplants, particularly for thalassaemia major and leukaemia cases.
- Cordlife Group Limited (Parent Company)coreCordlife Medical Phils., Inc. is a subsidiary of Cordlife Group Limited, a Singapore Exchange Mainboard listed company. The parent company provides operational support, quality standards, and access to the broader network of seven facilities across Asia.
Scale indicators10 records
Recent moves6 records
Expansion highlights4 records
Cordlife Medical Phils., Inc. competitors and assessment
Company assessmentDirect peers
- Cells4Life: Cells4Life is a UK-based private cord blood and tissue bank offering similar subscription-based multi-year storage services and competing on the same family-banking value proposition.
- ViaCord: ViaCord is a US private cord blood bank (formerly part of PerkinElmer/Revvity) offering comparable umbilical cord blood and cord tissue banking with multi-year storage and ancillary genetic services.
- Cryoviva Philippines: Cryoviva operates a competing private cord blood banking service in the Philippines with multi-country Asian presence, offering umbilical cord blood and other stem cell storage to expecting Filipino parents on a comparable subscription model.
- Stemcord Philippines: Stemcord is a Philippines-based private cord blood bank that directly competes with Cordlife Philippines for OB-GYN referrals, hospital collection partnerships, and expecting-parent enrollments under a similar 18-year storage proposition.
- HealthBaby Hong Kong: HealthBaby is a Cordlife Group cord blood bank serving Hong Kong with an overlapping service menu (cord blood banking, prenatal diagnostics) and similar regulatory positioning under the same AABB-accredited operating standards.
- StemLife Malaysia: StemLife is a Cordlife Group cord blood bank serving Malaysia with cord blood and cord lining storage offerings to expecting parents in Southeast Asia, comparable in product mix and target segment to Cordlife Philippines.
Regional players
- Singapore Cord Blood Bank: Singapore Cord Blood Bank is a non-profit public cord blood banking facility operating in the same regional market as Cordlife Group, providing a reference point for storage standards and donor-matching networks in Southeast Asia.
Broad incumbents
- Cryo-Cell International: Cryo-Cell is a US-listed, AABB-accredited cord blood and menstrual stem cell bank offering similar subscription-based family banking services; a benchmark international comparable on scale, accreditation, and pricing.
- Cord Blood Registry (CBR): CBR, now part of CooperSurgical, is one of the largest US private cord blood banks; comparable on subscription storage model, OB-GYN-led acquisition motion, and add-on genetic services.
- Cordlife Group (Singapore HQ): Listed parent entity of Cordlife Medical Philippines, providing the same cord blood and cord lining banking technology and brand across the Asian network; useful as the consolidated comparable for the group's scale and unit economics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Cordlife Medical Phils., Inc. social profiles
Digital presenceCordlife Medical Phils., Inc. compliance and trust
Trust signalCompliance3 records
Cordlife Medical Phils., Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cordlife Medical Phils., Inc. leadership team
Management profileNumber of profiles
Cordlife Medical Phils., Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cordlife Medical Phils., Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cordlife Medical Phils., Inc.
What does Cordlife Medical Phils., Inc. do?
Cordlife Medical Phils., Inc. collects, processes, and cryogenically stores umbilical cord blood and cord lining stem cells at its Quezon City facility for Filipino expecting parents. The company offers 18-year storage plans covering the child, parents, and grandparents. It also provides prenatal and pediatric diagnostic services including non-invasive prenatal testing (NIPT) using whole genome sequencing and baby genetic screening for 241 rare diseases.
Is Cordlife Medical Phils., Inc. a public or private company?
Cordlife Medical Phils., Inc. is a private company. It is classified as corporate owned and is currently operating.
When was Cordlife Medical Phils., Inc. founded?
Cordlife Medical Phils., Inc. was founded in 2008. It employs 51 to 100 people.
Where is Cordlife Medical Phils., Inc. based?
Cordlife Medical Phils., Inc. is headquartered in Quezon City, Philippines, in the Asia region.
How does Cordlife Medical Phils., Inc. make money?
Six revenue lines are on record. Umbilical Cord Blood Banking is the primary driver. The others are umbilical Cord Lining Banking, cordlife NIPT (Non-Invasive Prenatal Testing), baby Genetic Screening, value-Added Services and plan Upgrade Services.
Who are Cordlife Medical Phils., Inc.'s main competitors?
Direct peers on record are Cells4Life, ViaCord, Cryoviva Philippines, Stemcord Philippines, HealthBaby Hong Kong and StemLife Malaysia. Singapore Cord Blood Bank is listed as a regional player. Broad incumbents are Cryo-Cell International, Cord Blood Registry (CBR) and Cordlife Group (Singapore HQ).
Does Cordlife Medical Phils., Inc. have an API?
No public API is recorded for Cordlife Medical Phils., Inc..
What industry is Cordlife Medical Phils., Inc. in?
Cordlife Medical Phils., Inc.'s product category is Stem Cell Banking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening). Its NAICS code is 621991 and its SIC code is 2836.